Brief: Bio Vitos Pharma Q4 Pre-Tax Loss Widens To SEK 5.1 Mln
Feb 14 (Reuters) - Bio Vitos Pharma AB BIOVIT.ST :
* Q4 NET REVENUE SEK 819,302 VERSUS SEK 595,790 YEAR AGO
* Q4 PRE-TAX LOSS SEK 5.1 MILLION VERSUS LOSS 2.9 MILLION
YEAR AGO
Source text for Eikon: ID:nWkrM2KxB
Further company coverage: BIOVIT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln